Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CTMX US Equity

CytomX Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1501989 · FY ends Dec 31
$3.57
+0.18 (+5.31%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 5 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Point72 Asset Management, L.P.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Kynam Capital Management, LPsec.gov ↗
2026-08-0713GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0313GSchedule 13G filed — ≥5% beneficial owner (passive) · by BANK OF AMERICA CORP /DE/sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-278-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-27

Every row is a filed document, checked against its EDGAR index.